Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis.

Kufukihara K, Watanabe Y, Inagaki T, Takamatsu K, Nakane S, Nakahara J, Ando Y, Suzuki S.

Sci Rep. 2019 Mar 27;9(1):5284. doi: 10.1038/s41598-019-41730-z.

2.

Inflammatory myopathy associated with PD-1 inhibitors.

Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, Ohira M, Isami A, Hiramatsu S, Hibino M, Nakane S, Noda S, Yutani S, Hanazono A, Yaguchi H, Takao M, Shiina T, Katsuno M, Nakahara J, Matsubara S, Nishino I, Suzuki S.

J Autoimmun. 2019 Jun;100:105-113. doi: 10.1016/j.jaut.2019.03.005. Epub 2019 Mar 10.

PMID:
30862448
3.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

4.

CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers.

Mizutani H, Nakane S, Ikeda T, Nakamura H, Takamatsu K, Makino K, Tawara N, Mukaino A, Watari M, Matsui H, Mukasa A, Ando Y.

Ann Clin Transl Neurol. 2018 Oct 19;5(12):1611-1616. doi: 10.1002/acn3.668. eCollection 2018 Dec.

5.

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.

Takamatsu K, Nakane S, Suzuki S, Kosaka T, Fukushima S, Kimura T, Miyashita A, Mukaino A, Yamakawa S, Watanabe K, Jinnin M, Komohara Y, Ihn H, Ando Y.

Ann Clin Transl Neurol. 2018 Sep 23;5(11):1421-1427. doi: 10.1002/acn3.654. eCollection 2018 Nov.

6.

A case of autoimmune autonomic ganglionopathy with prolonged delirium.

Uenishi S, Takahashi S, Nakayama Y, Hiwatani Y, Nakane S, Tsuji T, Ukai S.

Asian J Psychiatr. 2019 Jan;39:8-9. doi: 10.1016/j.ajp.2018.11.003. Epub 2018 Nov 13.

PMID:
30466057
7.

Impact of major earthquakes on Parkinson's disease.

Kurisaki R, Ueyama H, Maeda Y, Sakamoto T, Nakahara K, Nakane S, Yamashita S, Ando Y; 2016 Kumamoto Earthquake PD Study Group.

J Clin Neurosci. 2019 Mar;61:130-135. doi: 10.1016/j.jocn.2018.10.107. Epub 2018 Nov 13.

PMID:
30446368
8.

Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment.

Nakane S, Mukaino A, Higuchi O, Watari M, Maeda Y, Yamakawa M, Nakahara K, Takamatsu K, Matsuo H, Ando Y.

Expert Rev Neurother. 2018 Dec;18(12):953-965. doi: 10.1080/14737175.2018.1540304. Epub 2018 Nov 1.

PMID:
30352532
9.

Autoimmune autonomic ganglionopathy associated with Sjögren's syndrome presenting with recurrent abdominal distension.

Yoshida T, Kinjo M, Nakane S.

BMJ Case Rep. 2018 Oct 2;2018. pii: bcr-2017-223785. doi: 10.1136/bcr-2017-223785.

PMID:
30279247
10.

CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.

Nakane S, Fujita K, Azuma S, Urushihara R, Kamada M, Harada M, Izumi Y, Kaji R.

Clin Neurol Neurosurg. 2018 Sep;172:162-168. doi: 10.1016/j.clineuro.2018.07.008. Epub 2018 Jul 10.

PMID:
30016754
11.

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Horio Y, Takamatsu K, Tamanoi D, Sato R, Saruwatari K, Ikeda T, Nakane S, Nakajima M, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Eur J Immunol. 2018 Oct;48(10):1764-1767. doi: 10.1002/eji.201847645. Epub 2018 Jul 19.

PMID:
29981156
12.

Anti-ganglionic AChR antibodies in Japanese patients with motility disorders.

Mukaino A, Minami H, Isomoto H, Hamamoto H, Ihara E, Maeda Y, Higuchi O, Okanishi T, Kokudo Y, Deguchi K, Sasaki F, Ueki T, Murata KY, Yoshida T, Kinjo M, Ogawa Y, Ido A, Matsuo H, Nakao K, Nakane S.

J Gastroenterol. 2018 Dec;53(12):1227-1240. doi: 10.1007/s00535-018-1477-8. Epub 2018 May 15.

PMID:
29766276
13.

Autoimmune postural orthostatic tachycardia syndrome.

Watari M, Nakane S, Mukaino A, Nakajima M, Mori Y, Maeda Y, Masuda T, Takamatsu K, Kouzaki Y, Higuchi O, Matsuo H, Ando Y.

Ann Clin Transl Neurol. 2018 Feb 28;5(4):486-492. doi: 10.1002/acn3.524. eCollection 2018 Apr.

14.

[Anti-Ganglionic Acetylcholine Receptor Antibodies, Autoimmune Autonomic Ganglionopathy, and Related Disorders].

Nakane S, Watari M, Ando Y.

Brain Nerve. 2018 Apr;70(4):383-393. doi: 10.11477/mf.1416201011. Japanese.

PMID:
29632286
15.

Pilot Study of a Device to Induce the Hanger Reflex in Patients with Cervical Dystonia.

Asahi T, Sato M, Nakamura T, Kon Y, Kajimoto H, Oyama G, Hayashi A, Tanaka K, Nakane S, Takeshima T, Fujii M, Kuroda S.

Neurol Med Chir (Tokyo). 2018 May 15;58(5):206-211. doi: 10.2176/nmc.oa.2017-0111. Epub 2018 Mar 31.

16.

Yips preceding baseball-related dystonia.

Nakane S, Ando Y, Matsuo H.

Parkinsonism Relat Disord. 2018 May;50:128-129. doi: 10.1016/j.parkreldis.2018.02.018. Epub 2018 Feb 11. No abstract available.

PMID:
29452955
17.

[The interface between the immune system and autonomic nervous system].

Nakane S, Mukaino A, Ando Y.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(5):352-360. doi: 10.2177/jsci.40.352. Review. Japanese.

18.

Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus.

Ichinose K, Ohyama K, Furukawa K, Higuchi O, Mukaino A, Satoh K, Nakane S, Shimizu T, Umeda M, Fukui S, Nishino A, Nakajima H, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yoshida M, Kuroda N, Kawakami A.

Clin Immunol. 2018 Aug;193:123-130. doi: 10.1016/j.clim.2017.11.006. Epub 2017 Nov 21.

PMID:
29162406
19.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group.

Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Erratum in: Lancet Neurol. 2017 Dec;16(12 ):954.

PMID:
29066163
20.

Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma.

Ishikawa H, Taniguchi A, Ii Y, Higuchi O, Matsuo H, Nakane S, Asahi M, Niwa A, Tomimoto H.

Neuromuscul Disord. 2017 Oct;27(10):914-917. doi: 10.1016/j.nmd.2017.06.001. Epub 2017 Jun 3.

PMID:
28694075

Supplemental Content

Loading ...
Support Center